Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $472.0000 (-3.99%) ($471.2600 - $490.1700) on Tue. Aug. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 41 | Latest Price | $472.0000(-3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.6% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(43%) IVW(42%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities). UUP(-9%) VIXM(-7%) TLT(-6%) TIP(-2%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | 0 () | Intraday Trend | -3% | | | |
|
Resistance Level | $502.8 | 5 Day Moving Average | $499.27(-5.46%) | 10 Day Moving Average | $506.84(-6.87%) | 20 Day Moving Average | $502.8(-6.13%) | To recent high | -10.4% | To recent low | 19.1% | Market Cap | $50.046b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |